China bars researchers, sanctions hospital officials in gene therapy ethics scandal

China's investigation into a gene therapy scandal has resulted in two researchers being barred from projects and awards for five years, and hospital officials sanctioned for research misconduct and ethics violations. The action signals a tightening of oversight in biomedical research, though details on the specific therapy and affected patients remain unclear. This is a notable regulatory enforcement step in China's health sector.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works